Breakthrough! Fuhong Hanlin (02696) H Drug Hansen has been granted breakthrough therapy designation by CDE, becoming the first immune innovative drug for perioperative gastric cancer.

Zhtng Cijng APP huxn, 2025 nin 11 yu 20 r, f hng hn ln (02696) xunb, chung xn xng PD-1 yzh j H yo hn s zhung (s l l dn kng, u zhu shngpn mng : Hetronifly) bi guji yo pn jin d gunl j (NMPA) yo pn shnpng gunl zhngxn (CDE) zhngsh nr tp xng zhlio pnzhng mngdn, linh hulio yngy xn fzh/fzh zhlio gi'n, chng wi shu g hu CDE tp xng lxing rndng de wishu q zhlio yow de ynwi q zhlio yow.